Tineа Corporis with Trichophyton Rubrum Mimicking a Flare-Up of Psoriasis UnderTreatment with IL17-Inhibitor Ixekizumab.
IL-17-inhibitor
Ixekizumab
Psoriasis
Tinea
Journal
Case reports in dermatology
ISSN: 1662-6567
Titre abrégé: Case Rep Dermatol
Pays: Switzerland
ID NLM: 101517685
Informations de publication
Date de publication:
Historique:
received:
20
10
2020
accepted:
07
03
2021
entrez:
30
7
2021
pubmed:
31
7
2021
medline:
31
7
2021
Statut:
epublish
Résumé
Biologics, as IL17 inhibitors, are frequently prescribed for moderate to severe plaque psoriasis. Although mucocutaneous candida infections are a well-known side effect of IL-17 inhibitors, there is no data about dermatophyte infection under this therapy. Generalized tinea corporis can mimic the clinical picture of psoriasis, especially if concomitant treatment with topical corticosteroids is used. Therefore, physician should be aware of this differential diagnosis if they suspect a loss of efficacy of IL-17-inhibitors with a flare-up of psoriasis.
Identifiants
pubmed: 34326729
doi: 10.1159/000515702
pii: cde-0013-0347
pmc: PMC8299392
doi:
Types de publication
Case Reports
Langues
eng
Pagination
347-351Informations de copyright
Copyright © 2021 by S. Karger AG, Basel.
Déclaration de conflit d'intérêts
Nikhil Yawalkar and Kristine Heidemeyer have served as consultants for Eli Lilly. The remaining authors declare no conflict of interest.
Références
J Am Acad Dermatol. 2017 Mar;76(3):432-440.e17
pubmed: 27889292
Curr Opin Microbiol. 2012 Aug;15(4):420-6
pubmed: 22818901
Br J Dermatol. 2018 Mar;178(3):674-681
pubmed: 28991370
J Am Acad Dermatol. 2017 Nov;77(5):855-862
pubmed: 28917383
J Clin Aesthet Dermatol. 2020 Sep;13(9 Suppl 1):S21-S25
pubmed: 33349790
Br J Dermatol. 2017 Oct;177(4):1014-1023
pubmed: 28542874
Br J Dermatol. 2020 Jun;182(6):1348-1358
pubmed: 31887225
Dermatol Ther (Heidelb). 2016 Mar;6(1):25-37
pubmed: 26910853
Int J Mol Sci. 2019 Mar 23;20(6):
pubmed: 30909615
Eur J Immunol. 2012 Sep;42(9):2246-54
pubmed: 22949323
JAMA Dermatol. 2016 Apr;152(4):486-7
pubmed: 26720159
Dermatol Ther (Heidelb). 2020 Feb;10(1):133-150
pubmed: 31749092